Of note, overexpression of all these 7 genes were associated with low OS in patients with LGG (Figure 8B–8H), which indicated METTL21B could be involved tumor immune escape and promote progression by regulating expression of immune checkpoints. This evidence concerns the gene EEF1AKMT3 and neoplasm.